About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 6604 record(s)
Req # A-2024-000127
Documents and records containing information regarding the mock-ups of every label to be used in connection with the Second Semaglutide Abbreviated New Drug Submission (ANDS).Organization: Health Canada
October 2024
Req # A-2024-000201
Any internal communications or communications by/from Cannabis and Controlled Substances Branch to governmental agencies or any draft communications questioning whether a cannabis product with a brand element or brand name or product name containing…Organization: Health Canada
October 2024
Req # A-2024-000209
The Standard Operating Procedure on Signal Response Protocol between Health Canada and the Public Health Agency of Canada which includes a Common Core Issues Management Process for COVID-19 Vaccines.Organization: Health Canada
October 2024
Req # A-2024-000210
All of the communications, memos, revisions, emails, attachments, briefs, meeting notes that Dr Supriya Sharma made with respect to the Vaccine Reporting Webpage from January 2020 to May 22, 2024.Organization: Health Canada
October 2024
Req # A-2024-000458
Seeking drug product testing and/or lot release results conducted by Health Canada or any other external party concerning Comirnaty COVID-19 vaccine and SpikeVax COVID-19 vaccines.Organization: Health Canada
October 2024
Req # A-2024-000471
The Imperial Tobacco Canada Ltd. submission in response to the Consultation on the Legislative Review of the Tobacco and Vaping Products Act <https://www.canada.ca/en/health-canada/programs/consultation-legislative-review-tobacco-vaping-products-…Organization: Health Canada
October 2024
Req # A-2024-000496
The most current status of the Abbreviated New Drug Submission (ANDS) seeking approval of a generic degarelix acetate product, which was accepted into review by Health Canada in January 2024: Inactive; Process; Process Hold; Withdrawn. If the status…Organization: Health Canada
October 2024
Req # A-2024-000497
Provide a screenshot of the status page for the Degarelix Acetate Abbreviated New Drug Submission (ANDS) on the Drug Submission Tracking System (DSTS) interface.Organization: Health Canada
October 2024
Req # A-2024-000530
If the Nov 2023 Liraglutide Abbreviated New Drug Submission (ANDS) has received a Notice of Deficiency (NOD); a Notice of Non-Compliance (NON); a NOD-Withdrawal (NOD-W); or a NON-Withdrawal (NON-W), provide the month and year that the notice was…Organization: Health Canada
October 2024
Req # A-2024-000532
A screenshot of the status page for the April 2024 Liraglutide Abbreviated New Drug Submission (ANDS) on the Drug Submission Tracking System (DSTS) interface.Organization: Health Canada
October 2024